• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

SERUM CYSTATIN C AS AN EARLY DIAGNOSTIC MARKER FOR THE DETECTION OF NEPHROPATHY IN TYPE 2 DIABETES MELLITUS

    Dr. P.Jayakala, Dr. J S Mounika

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 10424-10429

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

One of the most common causes of dialysis is diabetic nephropathy (DN), which can be
prevented or delayed with early identification. When it comes to chronic kidney disease (CKD)
and type 2 diabetes, little is known about the renal function marker serum cystatin C (sCysC) and
its link to glomerular filtration rate. In this study, we tested the efficacy of sCysC as a marker of
early DN and CKD in patients from the southern Indian coastal region
Keywords:
    Glomerular filtration rate Diabetic nephropathy chronic renal disease cystatin C
  • PDF (171 K)
  • XML
(2022). SERUM CYSTATIN C AS AN EARLY DIAGNOSTIC MARKER FOR THE DETECTION OF NEPHROPATHY IN TYPE 2 DIABETES MELLITUS. European Journal of Molecular & Clinical Medicine, 9(3), 10424-10429.
Dr. P.Jayakala, Dr. J S Mounika. "SERUM CYSTATIN C AS AN EARLY DIAGNOSTIC MARKER FOR THE DETECTION OF NEPHROPATHY IN TYPE 2 DIABETES MELLITUS". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 10424-10429.
(2022). 'SERUM CYSTATIN C AS AN EARLY DIAGNOSTIC MARKER FOR THE DETECTION OF NEPHROPATHY IN TYPE 2 DIABETES MELLITUS', European Journal of Molecular & Clinical Medicine, 9(3), pp. 10424-10429.
SERUM CYSTATIN C AS AN EARLY DIAGNOSTIC MARKER FOR THE DETECTION OF NEPHROPATHY IN TYPE 2 DIABETES MELLITUS. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 10424-10429.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 71
  • PDF Download: 100
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus